Organic compounds
- 专利权人:
- INTRA-CELLULAR THERAPIES; INC.
- 发明人:
- Peng Li,Youyi Peng,John Tomesch,Lawrence P. Wennogle,Qiang Zhang
- 申请号：
- US14993048
- 公开号：
- US09708294B2
- 申请日:
- 2016.01.11
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- The invention relates to compounds and methods of treatment relating to nicotinic receptor antagonists. For example, the compounds and methods of treatment function block the activity of certain acetylcholine receptors and subtypes therein, and are useful treating diseases and conditions mediated by nicotinic receptor stimulation, e.g., small cell lung cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- HETEROCYLIC COMPOUNDS AS ANTAGONISTS OF THE OREXIN RECEPTORS
- Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
- USE OF TOLL-LIKE RECEPTOR-9 AGONISTS, TOLL-LIKE RECEPTOR-4 ANTAGONISTS, AND/OR NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS FOR THE TREATMENT OF PREVENTION OF TOLL-LIKE RECEPTOR-4-ASSOCIATED DISORDERS
- Use of Toll-like receptor-9 agonists, Toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of Toll-like receptor-4-associated disorders
- INDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS
